Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

387 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical pharmacokinetics of tyrosine kinase inhibitors.
van Erp NP, Gelderblom H, Guchelaar HJ. van Erp NP, et al. Among authors: guchelaar hj. Cancer Treat Rev. 2009 Dec;35(8):692-706. doi: 10.1016/j.ctrv.2009.08.004. Epub 2009 Sep 5. Cancer Treat Rev. 2009. PMID: 19733976 Review.
Cardiotoxicity of cytotoxic drugs.
Schimmel KJ, Richel DJ, van den Brink RB, Guchelaar HJ. Schimmel KJ, et al. Among authors: guchelaar hj. Cancer Treat Rev. 2004 Apr;30(2):181-91. doi: 10.1016/j.ctrv.2003.07.003. Cancer Treat Rev. 2004. PMID: 15023436 Review.
The risk of cancer in users of statins.
Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ. Graaf MR, et al. Among authors: guchelaar hj. J Clin Oncol. 2004 Jun 15;22(12):2388-94. doi: 10.1200/JCO.2004.02.027. J Clin Oncol. 2004. PMID: 15197200
Is rectal administration an alternative route for imatinib?
van Erp NP, Oostendorp RL, Guchelaar HJ, Schellens JH, Gelderblom H. van Erp NP, et al. Among authors: guchelaar hj. Cancer Chemother Pharmacol. 2007 Sep;60(4):623-4. doi: 10.1007/s00280-006-0409-0. Epub 2007 Feb 8. Cancer Chemother Pharmacol. 2007. PMID: 17287936 No abstract available.
Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib.
van Erp NP, Gelderblom H, Karlsson MO, Li J, Zhao M, Ouwerkerk J, Nortier JW, Guchelaar HJ, Baker SD, Sparreboom A. van Erp NP, et al. Among authors: guchelaar hj. Clin Cancer Res. 2007 Dec 15;13(24):7394-400. doi: 10.1158/1078-0432.CCR-07-0346. Clin Cancer Res. 2007. PMID: 18094422 Clinical Trial.
387 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page